Galen Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Galen Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3409
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galen Ltd (Galen), a subsidiary of Almac Group Ltd, is a pharmaceutical company. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angina, constipation, HIV-related Kaposi’s sarcoma (KS), osteoporosis, overactive bladder, painful bladder syndrome and interstitial cystitis, and skin lesions and warts. Galen partners with international pharmaceutical and biotech companies to commercialize and expand its products. The company markets its products across the UK, Ireland, Europe and the US. It operates in the UK and the US. Galen is headquartered in Craigavon, the UK.

Galen Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galen Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Galen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galen Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Galen Acquires US Rights to ADASUVE from Alexza Pharma 11
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 12
Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13
Licensing Agreements 14
Galen Enters Into Licensing Agreement With Medical Developments International For Penthrox 14
Galen Ltd – Key Competitors 15
Galen Ltd – Key Employees 16
Galen Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Galen Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galen Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galen Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Galen Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Galen Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Galen Acquires US Rights to ADASUVE from Alexza Pharma 11
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 12
Galen Acquires DaunoXome, Chemotherapy Agent, From Gilead Sciences 13
Galen Enters Into Licensing Agreement With Medical Developments International For Penthrox 14
Galen Ltd, Key Competitors 15
Galen Ltd, Key Employees 16
Galen Ltd, Subsidiaries 17

List of Figures
Galen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Galen Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Galen Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Galen Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Galen Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Faron Pharmaceuticals Oy (FARN):企業の財務・戦略的SWOT分析
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that develops treatments for unmet medical needs. The company is developing pipeline products with a focus on vascular damage, acute organ traumas and cancer immunotherapy. It offers Clevegen, a humanized Clever-1 …
  • The InterTech Group, Inc.:企業の戦略的SWOT分析
    The InterTech Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Techno – Agricultural Supplying (TSC):企業の財務・戦略的SWOT分析
    Techno - Agricultural Supplying (TSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • The Siam Commercial Bank Public Company Limited:企業の戦略・SWOT・財務分析
    The Siam Commercial Bank Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Siam Commercial Bank Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • AZTherapies Inc-製薬・医療分野:企業M&A・提携分析
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer’s disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the le …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose) is an investment company that improve and sell industrial and manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipment. Its business portfolio comprises of Norte …
  • Landec Corp (LNDC):企業の財務・戦略的SWOT分析
    Summary Landec Corp (Landec) is a diversified health solution service provider. The company offers offers food and biomaterial solutions. It develops and markets innovative and proprietary based products for healthy living. The company offers various technologies such as application development and …
  • Imdex Limited (IMD)-石油・ガス分野:企業M&A・提携分析
    Summary Imdex Limited (Imdex) is a provider of integrated technological solutions to the mineral industry. The company offers drilling fluids, drilling equipment, advanced downhole instrumentation, data management solution and analytical software for geological modeling through its AMC and REFLEX br …
  • Europa Oil & Gas (Holdings) Plc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise value hearing health, biomedical solutions, hearing health manufacturing and professional audio. In addition it also …
  • Schroders Plc
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vietnam Technological and Commercial Joint Stock Bank (TCB):企業の財務・戦略的SWOT分析
    Vietnam Technological and Commercial Joint Stock Bank (TCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Santhera Pharmaceuticals Holding AG (SANN):製薬・医療:M&Aディール及び事業提携情報
    Summary Santhera Pharmaceuticals Holding AG (Santhera) develops and commercializes novel pharmaceutical products indicated for patients with mitochondrial and neuromuscular diseases. It specifically focuses in the area of neuromuscular and neuro-ophthalmological conditions. The company’s lead produc …
  • Brown & Brown Inc:企業の戦略・SWOT・財務分析
    Brown & Brown Inc - Strategy, SWOT and Corporate Finance Report Summary Brown & Brown Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Synthon Holdings BV:企業の戦略的SWOT分析
    Synthon Holdings BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Derma Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary Derma Sciences Inc (Derma Sciences) is a medical devices company. It focuses on advanced wound care and traditional wound care. Its advanced wound care product portfolio includes dermagran, silverseal, alginate dressing, aquasite hydrogel, primacol hydrocolloid, hydrocell foam and primaderm …
  • Clinigen Group Plc (CLIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Publix Super Markets Inc:企業の戦略的SWOT分析
    Publix Super Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆